Literature DB >> 10673294

Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival.

E V Loftus1, M D Silverstein, W J Sandborn, W J Tremaine, W S Harmsen, A R Zinsmeister.   

Abstract

BACKGROUND: There is significant geographic variation in the reported incidence of ulcerative colitis. AIMS: To update the incidence and prevalence of ulcerative colitis in Olmsted County, Minnesota, examine temporal trends, and determine overall survival. PATIENTS: All Olmsted County residents diagnosed with ulcerative colitis between 1940 and 1993 (incidence cases), and all residents with ulcerative colitis alive on 1 January 1991 (prevalence cases).
METHODS: Incidence and prevalence rates were adjusted using 1990 US census figures for whites. The effects of age, sex, and calendar year on incidence rates were evaluated using Poisson regression. Survival from diagnosis was compared with that expected for US north-central whites.
RESULTS: Between 1940 and 1993, 278 incidence cases were identified, for an adjusted incidence rate of 7.6 cases per 100 000 person years (95% confidence interval (CI), 6.7 to 8.5). On 1 January 1991, there were 218 residents with definite or probable ulcerative colitis, for an adjusted prevalence rate of 229 cases per 100 000 (95% CI, 198 to 260). Increased incidence rates were associated with later calendar years (p<0.002), younger age (p<0.0001), urban residence (p<0.0001), and male sex (p<0.003). Overall survival was similar to that expected (p>0.2).
CONCLUSIONS: The overall incidence rate of ulcerative colitis in Olmsted County increased until the 1970s, and remained stable thereafter. Incidence rates among men and urban residents were significantly higher. The prevalence rate in Rochester in 1991 was 19% higher than that in 1980. Overall survival was similar to that of the general population.

Entities:  

Mesh:

Year:  2000        PMID: 10673294      PMCID: PMC1727835          DOI: 10.1136/gut.46.3.336

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  39 in total

1.  Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study.

Authors:  C N Bernstein; J F Blanchard; P Rawsthorne; A Wajda
Journal:  Am J Epidemiol       Date:  1999-05-15       Impact factor: 4.897

2.  Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982.

Authors:  J H Gollop; S F Phillips; L J Melton; A R Zinsmeister
Journal:  Gut       Date:  1988-01       Impact factor: 23.059

3.  The patient record in epidemiology.

Authors:  L T Kurland; C A Molgaard
Journal:  Sci Am       Date:  1981-10       Impact factor: 2.142

4.  Inflammatory bowel disease in northern Alberta. An epidemiologic study.

Authors:  B R Pinchbeck; J Kirdeikis; A B Thomson
Journal:  J Clin Gastroenterol       Date:  1988-10       Impact factor: 3.062

5.  Incidence of ulcerative colitis in Stockholm County 1955-1979.

Authors:  B Nordenvall; O Broström; M Berglund; U Monsen; J Nordenström; J Sörstad; G Hellers
Journal:  Scand J Gastroenterol       Date:  1985-09       Impact factor: 2.423

6.  An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence.

Authors:  S P Stowe; S R Redmond; J M Stormont; A N Shah; L N Chessin; H L Segal; W Y Chey
Journal:  Gastroenterology       Date:  1990-01       Impact factor: 22.682

7.  Prognosis of chronic ulcerative colitis in a community.

Authors:  C M Stonnington; S F Phillips; A R Zinsmeister; L J Melton
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

8.  Chronic ulcerative colitis: incidence and prevalence in a community.

Authors:  C M Stonnington; S F Phillips; L J Melton; A R Zinsmeister
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

9.  Geographic variation of inflammatory bowel disease within the United States.

Authors:  A Sonnenberg; D J McCarty; S J Jacobsen
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

10.  Epidemiology of inflammatory bowel disease in a defined northern California population.

Authors:  R A Hiatt; L Kaufman
Journal:  West J Med       Date:  1988-11
View more
  124 in total

Review 1.  Management of Ulcerative Colitis in the Elderly.

Authors:  Manish P Shrestha; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

2.  The incidence, prevalence, and survival of gastroparesis in olmsted county, Minnesota, 1996-2006 (gastroenterology 2009;136:1225-1233).

Authors:  Hye-Kyung Jung
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

3.  Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001.

Authors:  Laszlo Lakatos; Gabor Mester; Zsuzsanna Erdelyi; Mihaly Balogh; Istvan Szipocs; Gyorgy Kamaras; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

4.  Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics.

Authors:  Eun Soo Kim; Won Ho Kim
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

5.  Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes.

Authors:  Stephen B Hanauer; Daniel H Present; David T Rubin
Journal:  Gastroenterol Hepatol (N Y)       Date:  2009-06

6.  New Research in Ulcerative Colitis: Optimizing 5-ASA Administration for Efficacy and Adherence.

Authors:  Charles A Sninsky
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-01

Review 7.  Quality of care in inflammatory bowel disease.

Authors:  Brijen Shah; Andrew Tinsley; Thomas Ullman
Journal:  Curr Gastroenterol Rep       Date:  2011-02

8.  A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women.

Authors:  Leslie M Higuchi; Hamed Khalili; Andrew T Chan; James M Richter; Athos Bousvaros; Charles S Fuchs
Journal:  Am J Gastroenterol       Date:  2012-07-10       Impact factor: 10.864

Review 9.  Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.

Authors:  Millie D Long; Susan Hutfless; Michael D Kappelman; Hamed Khalili; Gilaad G Kaplan; Charles N Bernstein; Jean Frederic Colombel; Corinne Gower-Rousseau; Lisa Herrinton; Fernando Velayos; Edward V Loftus; Geoffrey C Nguyen; Ashwin N Ananthakrishnan; Amnon Sonnenberg; Andrew Chan; Robert S Sandler; Ashish Atreja; Samir A Shah; Kenneth J Rothman; Neal S Leleiko; Renee Bright; Paolo Boffetta; Kelly D Myers; Bruce E Sands
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

10.  Lack of utility of symptoms and signs at first presentation as predictors of inflammatory bowel disease in secondary care.

Authors:  Alexander C Ford; Paul Moayyedi; Premysl Bercik; David G Morgan; Carolina Bolino; Maria I Pintos-Sanchez; Walter Reinisch
Journal:  Am J Gastroenterol       Date:  2015-04-28       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.